Calidi Biotherapeutics secures $600K loan at 15% interest from Dennis Conklin

Calidi Biotherapeutics, Inc.

Loan agreement with Dennis R. Conklin for principal amount of $600,000.
Note bears simple interest at 15% per annum, matures three years from July 2, 2024.
Interest payable annually after each calendar year; principal and remaining interest due at maturity.
Proceeds received on July 2, 2024; use of proceeds not specified.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.